This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See the presentation recording below. https://vimeo.com/711710496
COVID-19 and Low-Dose Radiation Therapy: Current Concepts and Clinical Results
read more
Area of Interest
RADiant Overview by Xstrahl’s CEO, Adrian Treverton
Learn about RADiant from Xstrahl's CEO, Adrian Treverton. RADiant is a portable and easy-to-use system that can treat a range of skin conditions, including skin cancer. https://vimeo.com/711329383
Radiotherapy for Dupuytren’s Disease
Dupuytren's contracture and Ledderhose disease are common, with rates of 20% of the population over the age of 65 having either disease. The diseases causes a debilitating curling of fingers and toes. The most common treatment is surgery, which can cause a long-term...
SARRP Used in HCC Radiation Research
In the study, Hepa 1-6: A murine model of hepatocellular carcinoma, Labcorp researcher, Sumithra Urs, studied an HCC tumor model's response to radiation with SARRP. See more below and the full article here.
Radiotherapy for Inflammatory Conditions
This recording is from the first session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/710910255
Radiotherapy for Hyperproliferative Disorders
This recording is from the second session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/710916275
Radiotherapy for Benign Skin Conditions
This recording is from the third session of Xstrahl's 2021 clinical symposia, Radiotherapy for Benign Conditions. https://vimeo.com/711325664
Radiotherapy for Benign Disease: Assessing the Risk of Radiation-Induced Cancer
Low Dose Radiation Therapy for COVID-19: Effective Dose and Estimation of Cancer Risk
Contact Us